H.I.G. Realty Forms Strategic Partnership
H.I.G. Capital, a renowned global alternative investment firm, is excited to announce a new strategic partnership with Queen Mary BioEnterprises Innovation Centre. This collaboration is set to create an expansive incubator space in London, measuring 40,000 square feet at their prominent innovation hub in Whitechapel.
Significant Collaborations in Life Sciences
In partnership with Lateral, a leading UK real estate developer, H.I.G. will work alongside various institutions, including Barts Life Sciences, Barts Health NHS Trust, and Queen Mary University of London. This collaboration is a pivotal advancement for the Whitechapel Life Science Cluster, reinforcing efforts to establish a world-class facility focused on developing transformative healthcare solutions.
Creating a Thriving Ecosystem for Startups
The new incubator space will not only serve as a platform for potential startups but also as an environment that nurtures innovation through shared services. Queen Mary BioEnterprises brings valuable experience in facilitating similar spaces, making it an ideal partner in delivering high-quality jobs and enriching career pathways in the life sciences and STEM fields.
Leadership Insights and Regional Impact
Jérôme Fouillé, Managing Director at H.I.G. Realty, expressed his enthusiasm about the partnership, stating, "We are thrilled to partner with QMB in developing this first-class incubator space at Cavell Street. Our collaboration marks a significant step in creating a vibrant life sciences cluster in Whitechapel and furthering the growth of H.I.G.'s life sciences real estate platform in the U.K." The development aims to provide top-notch facilities and services that support innovative startups eager to make a lasting impact in health outcomes.
Vision for the Future of Life Sciences
Ted Webster, Chairman of QMB, shared his excitement, noting, "Our partnership with H.I.G. is an exciting opportunity to expand our proven model of supporting life science startups. The new space will enable us to nurture the next generation of innovative companies, providing them with the resources and conditions they need to succeed." This vision ultimately revolves around advancing scientific progress and fostering benefits for the local community.
About Queen Mary BioEnterprises Innovation Centre
The Queen Mary BioEnterprises Innovation Centre has established its reputation since opening in 2011, having become the first newly built facility in London dedicated to both early and late-stage biotech firms. With 39,000 square feet of commercial wet laboratory and office space, QMB has been instrumental in cultivating innovative firms and facilitating access to Queen Mary University’s prestigious School of Medicine and Dentistry. The evolution to a larger incubator space aims to further support emerging companies in life sciences.
About H.I.G. Capital
H.I.G. Capital encompasses a wide realm of investment strategies with $67 billion in capital under management. Founded in 1993, the firm has invested in more than 400 companies globally, with its current portfolio comprising over 100 firms that boast annual sales exceeding $53 billion. Based in Miami, H.I.G. specializes in providing both debt and equity to mid-sized businesses, employing a flexible, operationally-focused approach.
Contact Information
For inquiries, you can reach out to: Riccardo Dallolio, Managing Director, H.I.G. Capital, London. You can also explore more about H.I.G. on their website. Reach out today for engaging conversations on life sciences investments or partnership opportunities.
Frequently Asked Questions
What is the focus of the strategic partnership?
The partnership aims to develop a 40,000 square-foot incubator space to support life sciences startups and foster innovation.
Who are the key partners involved?
The partnership involves H.I.G. Capital, Queen Mary BioEnterprises, Lateral, and several reputable institutions including Barts Life Sciences.
How will this project impact the local economy?
The incubator is expected to create high-quality job opportunities and support career pathways in life sciences and STEM fields.
What experience does QMB bring to this partnership?
QMB has a successful track record of supporting biotech startups and will leverage its experience to provide the necessary resources for new companies.
What is H.I.G.’s investment strategy?
H.I.G. specializes in both debt and equity investments, focusing on mid-sized companies with a value-added approach to enhance performance.
